{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T19:47:30Z","timestamp":1789069650715,"version":"build-2803163510"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.2215\/cjn.05830518","type":"journal-article","created":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T14:04:38Z","timestamp":1548252278000},"page":"364-377","source":"Crossref","is-referenced-by-count":45,"title":["Complement Gene Variants and Shiga Toxin\u2013Producing Escherichia coli\u2013Associated Hemolytic Uremic Syndrome"],"prefix":"10.2215","volume":"14","author":[{"given":"V\u00e9ronique","family":"Fr\u00e9meaux-Bacchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Sellier-Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Vieira-Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Limou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Lahoche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Novo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Llanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwena\u00eblle","family":"Roussey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Cailliez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Ulinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Desch\u00eanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Weill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Loirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"B1-20230601","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/S0140-6736(73)92645-7","article-title":"Letter: Plasma-C3 in haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura.","volume":"2","author":"Cameron","year":"1973","journal-title":"Lancet"},{"key":"B2-20230601","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(73)92782-7","article-title":"Letter: Serum-complement levels in haemolytic-uraemic syndrome.","volume":"2","author":"Kaplan","year":"1973","journal-title":"Lancet"},{"key":"B3-20230601","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1159\/000187063","article-title":"Hypocomplementemia and leukocytosis in diarrhea-associated hemolytic uremic syndrome.","volume":"62","author":"Robson","year":"1992","journal-title":"Nephron"},{"key":"B4-20230601","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0140-6736(17)30062-4","article-title":"Haemolytic uraemic syndrome.","volume":"390","author":"Fakhouri","year":"2017","journal-title":"Lancet"},{"key":"B5-20230601","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"key":"B6-20230601","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.2215\/CJN.02730409","article-title":"Alternative pathway of complement in children with diarrhea-associated hemolytic uremic syndrome.","volume":"4","author":"Thurman","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7-20230601","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1182\/blood-2010-09-309161","article-title":"Complement activation on platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced hemolytic uremic syndrome.","volume":"117","author":"St\u00e5hl","year":"2011","journal-title":"Blood"},{"key":"B8-20230601","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cei.12601","article-title":"Activation of the alternative pathway of complement during the acute phase of typical haemolytic uraemic syndrome.","volume":"181","author":"Ferraris","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B9-20230601","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1093\/ndt\/gfw078","article-title":"Systemic complement activation and complement gene analysis in enterohaemorrhagic Escherichia coli-associated paediatric haemolytic uraemic syndrome.","volume":"31","author":"Ahlenstiel-Grunow","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B10-20230601","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00467-016-3496-0","article-title":"Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.","volume":"32","author":"Westra","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"B11-20230601","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21767\/2472-5056.100011","article-title":"Typical Hus: Evidence of acute phase complement activation from a daycare outbreak.","volume":"1","author":"Brady","year":"2016","journal-title":"J Clin Exp Nephrol"},{"key":"B12-20230601","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.4049\/jimmunol.0900151","article-title":"Shiga toxin activates complement and binds factor H: Evidence for an active role of complement in hemolytic uremic syndrome.","volume":"182","author":"Orth","year":"2009","journal-title":"J Immunol"},{"key":"B13-20230601","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4049\/jimmunol.1100491","article-title":"Alternative pathway activation of complement by Shiga toxin promotes exuberant C3a formation that triggers microvascular thrombosis.","volume":"187","author":"Morigi","year":"2011","journal-title":"J Immunol"},{"key":"B14-20230601","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1681\/ASN.2013050450","article-title":"Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.","volume":"25","author":"Locatelli","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B15-20230601","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1182\/blood-2015-03-569277","article-title":"HUS and the case for complement.","volume":"126","author":"Conway","year":"2015","journal-title":"Blood"},{"key":"B16-20230601","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1093\/infdis\/jiv540","article-title":"Shiga toxin 2a-induced endothelial injury in hemolytic uremic syndrome: A Metabolomic Analysis.","volume":"213","author":"Betzen","year":"2016","journal-title":"J Infect Dis"},{"key":"B17-20230601","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000445770","article-title":"Induction of neutrophil extracellular traps in Shiga toxin-associated hemolytic uremic syndrome.","volume":"8","author":"Ramos","year":"2016","journal-title":"J Innate Immun"},{"key":"B18-20230601","article-title":"Shiga toxin triggers endothelial and podocyte injury: The role of complement activation [published online ahead of print December 6, 2017].","author":"Zoja","journal-title":"Pediatr Nephrol"},{"key":"B19-20230601","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1182\/blood-2007-04-084533","article-title":"Membrane cofactor protein mutations in atypical hemolytic uremic syndrome (aHUS), fatal Stx-HUS, C3 glomerulonephritis, and the HELLP syndrome.","volume":"111","author":"Fang","year":"2008","journal-title":"Blood"},{"key":"B20-20230601","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/j.ajkd.2007.08.030","article-title":"Association of a factor H mutation with hemolytic uremic syndrome following a diarrheal illness.","volume":"51","author":"Edey","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"B21-20230601","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype.","volume":"5","author":"Noris","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B22-20230601","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1111\/ajt.12297","article-title":"Two patients with history of STEC-HUS, posttransplant recurrence and complement gene mutations.","volume":"13","author":"Alberti","year":"2013","journal-title":"Am J Transplant"},{"key":"B23-20230601","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1681\/ASN.2006080811","article-title":"Differential impact of complement mutations on clinical characteristics in atypical hemolytic uremic syndrome.","volume":"18","author":"Sellier-Leclerc","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"B24-20230601","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1471-2431-14-278","article-title":"Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities.","volume":"14","author":"McCoy","year":"2014","journal-title":"BMC Pediatr"},{"key":"B25-20230601","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00467-015-3207-2","article-title":"CFH gene mutation in a case of Shiga toxin-associated hemolytic uremic syndrome (STEC-HUS).","volume":"31","author":"Caillaud","year":"2016","journal-title":"Pediatr Nephrol"},{"key":"B26-20230601","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1681\/ASN.2015010100","article-title":"De novo deletion in the regulators of complement activation cluster producing a hybrid complement factor H\/Complement Factor H-Related 3 gene in atypical hemolytic uremic syndrome.","volume":"27","author":"Challis","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B27-20230601","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/ckj\/sfx030","article-title":"Rare genetic variants in Shiga toxin-associated haemolytic uraemic syndrome: Genetic analysis prior to transplantation is essential.","volume":"10","author":"Dowen","year":"2017","journal-title":"Clin Kidney J"},{"key":"B28-20230601","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00431-015-2642-1","article-title":"Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.","volume":"175","author":"Ardissino","year":"2016","journal-title":"Eur J Pediatr"},{"key":"B29-20230601","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation.","volume":"526","author":"Auton","year":"2015","journal-title":"Nature"},{"key":"B30-20230601","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1093\/bioinformatics\/btw147","article-title":"Ferret: A user-friendly Java tool to extract data from the 1000 Genomes Project.","volume":"32","author":"Limou","year":"2016","journal-title":"Bioinformatics"},{"key":"B31-20230601","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans.","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"},{"key":"B32-20230601","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"B33-20230601","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.kint.2016.10.005","article-title":"Atypical hemolytic uremic syndrome and C3 glomerulopathy: Conclusions from a \u201cKidney Disease: Improving Global Outcomes\u201d (KDIGO) Controversies Conference.","volume":"91","author":"Goodship","year":"2017","journal-title":"Kidney Int"},{"key":"B34-20230601","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jim.2010.12.020","article-title":"Alternative complement pathway assessment in patients with atypical HUS.","volume":"365","author":"Roumenina","year":"2011","journal-title":"J Immunol Methods"},{"key":"B35-20230601","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molimm.2015.02.013","article-title":"Functional characterization of two novel non-synonymous alterations in CD46 and a Q950H change in factor H found in atypical hemolytic uremic syndrome patients.","volume":"65","author":"Mohlin","year":"2015","journal-title":"Mol Immunol"},{"key":"B36-20230601","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1056\/NEJMoa0810739","article-title":"Thrombomodulin mutations in atypical hemolytic-uremic syndrome.","volume":"361","author":"Delvaeye","year":"2009","journal-title":"N Engl J Med"},{"key":"B37-20230601","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1681\/ASN.2007080923","article-title":"The complement factor H R1210C mutation is associated with atypical hemolytic uremic syndrome.","volume":"19","author":"Martinez-Barricarte","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"B38-20230601","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.4049\/jimmunol.1701695","article-title":"Statistical validation of rare complement variants provides insights into the molecular basis of atypical hemolytic uremic syndrome and C3 glomerulopathy.","volume":"200","author":"Osborne","year":"2018","journal-title":"J Immunol"},{"key":"B39-20230601","doi-asserted-by":"crossref","first-page":"4948","DOI":"10.1182\/blood-2008-01-133702","article-title":"Mutations in complement C3 predispose to development of atypical hemolytic uremic syndrome.","volume":"112","author":"Fr\u00e9meaux-Bacchi","year":"2008","journal-title":"Blood"},{"key":"B40-20230601","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/ndt\/gfr422","article-title":"Thrombotic microangiopathy mimicking membranoproliferative glomerulonephritis.","volume":"26","author":"Brackman","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"B41-20230601","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.molimm.2006.10.005","article-title":"A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation.","volume":"44","author":"Nilsson","year":"2007","journal-title":"Mol Immunol"},{"key":"B42-20230601","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/ndt\/gft340","article-title":"Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.","volume":"28","author":"B\u00e9k\u00e1ssy","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"B43-20230601","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1086\/318201","article-title":"Clustering of missense mutations in the C-terminal region of factor H in atypical hemolytic uremic syndrome.","volume":"68","author":"P\u00e9rez-Caballero","year":"2001","journal-title":"Am J Hum Genet"},{"key":"B44-20230601","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1182\/blood-2014-10-609073","article-title":"Mapping interactions between complement C3 and regulators using mutations in atypical hemolytic uremic syndrome.","volume":"125","author":"Schramm","year":"2015","journal-title":"Blood"},{"key":"B45-20230601","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/cis196","article-title":"Need for long-term follow-up in enterohemorrhagic Escherichia coli-associated hemolytic uremic syndrome due to late-emerging sequelae.","volume":"54","author":"Rosales","year":"2012","journal-title":"Clin Infect Dis"},{"key":"B46-20230601","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","article-title":"Long-term outcomes of Shiga toxin hemolytic uremic syndrome.","volume":"28","author":"Spinale","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"B47-20230601","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00467-017-3876-0","article-title":"Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS).","volume":"33","author":"Exeni","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"B48-20230601","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/IAI.01079-12","article-title":"Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.","volume":"81","author":"Ehrlenbach","year":"2013","journal-title":"Infect Immun"},{"key":"B49-20230601","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2013-03-489245","article-title":"Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.","volume":"122","author":"Frimat","year":"2013","journal-title":"Blood"},{"key":"B50-20230601","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2215\/CJN.04760512","article-title":"Genetics and outcome of atypical hemolytic uremic syndrome: A nationwide French series comparing children and adults.","volume":"8","author":"Fremeaux-Bacchi","year":"2013","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201903000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:38:15Z","timestamp":1786369095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201903000-00009"}},"subtitle":["Retrospective Genetic and Clinical Study"],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.05830518","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]}}}